✨ Your Portfolio is fetched and updated from zerodha.
Small Services

Sun Pharma Advanced Research Company Ltd.

SPARC

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹5,223 Cr.
P/E
0.00

Sun Pharma Advanced Research Company Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
5,223 Cr
PE
PE
-
Prom Holding
Prom Holding
65.67 %
ROE (%)
ROE (%)
-307.91
ROCE (%)
ROCE (%)
-154.85
Div Yield (%)
Div Yield (%)
-
Sales
Sales
71.77 Cr
OPM (%)
OPM (%)
-450.24 %
Debt to Equity
Debt to Equity
0.37
View more
Edit Ratio's
About
SPARC is a clinical stage bio-pharmaceutical company dedicated to enhancing patient care world… Read more
Low
109
52W Range
High
241
  • Sun Pharma Adv. Res
  • Dishman Carbogen Amc
  • Zenotech Laboratorie
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Sun Pharma Advanced Research Company Ltd. Business

    SPARC is a clinical stage bio-pharmaceutical company specializing in pharmaceutical research and development to create innovative therapeutics and drug delivery systems for enhancing patient care globally.

    Sun Pharma Adv. Res major competitors are Dishman Carbogen Amc, Zenotech Laboratorie, Vivo Bio Tech, Jeevan Scientific, Syngene Internation., Hikal, Suven Life Sciences.
    Market Cap of Sun Pharma Adv. Res is ₹5,228 Crs.
    While the median market cap of its peers are ₹4,108 Crs.

    Sun Pharma Adv. Res seems to be less financially stable compared to its competitors.
    Altman Z score of Sun Pharma Adv. Res is 5.64 and is ranked 4 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    Discussions & Analysis
    Sun Pharma Advanced Research Company Ltd.
    Interview With Dilip Sanghvi, Managing Director - Sun Pharmaceutical Samir Mehta, Chairman - Torrent Pharma - Flame University
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material